HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Supplemental Data All Versions of this Article: 2007-0751v1 26/5/1315    most recent Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints/Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Fransioli, J. Articles by Sussman, M. A. Search for Related Content PubMed PubMed Citation Articles by Fransioli, J. Articles by Sussman, M. A.

TISSUE-SPECIFIC STEM CELLS

Evolution of the c-kit-Positive Cell Response to Pathological Challenge in the Myocardium

^aDepartment of Biology, San Diego State University Heart Institute, San Diego State University, San Diego, California, USA;
^bDipartimento Biotecnologie e Bioscienze, Università Milano-Bicocca-Piazza delle Scienze, Milan, Italy;
^cInvitrogen Corporation, Hopkinton, Massachusetts, USA

Key Words. c-kit • Heart • Infarction • Cardiac stem cell

Correspondence: Mark A. Sussman, Ph.D.,SDSU Heart Institute and Department of Biology, San Diego State University, 5500 Campanile Drive, San Diego, California 92182, USA. Telephone: 619-594-2983; Fax: 619-594-2610; e-mail: sussman{at}heart.sdsu.edu

Received September 7, 2007; accepted for publication February 21, 2008.
First published online in STEM CELLS EXPRESS   February 28, 2008.



Cumulative evidence indicates that myocardium responds to growth or injury by recruitment of stem and/or progenitor cells that participate in repair and regenerative processes. Unequivocal identification of this population has been hampered by lack of reagents or markers specific to the recruited population, leading to controversies regarding the nature of these cells. Use of a transgenic mouse expressing green fluorescent protein driven by the c-kit promoter allows for unambiguous identification of this cell population. Green fluorescent protein (GFP) driven by the c-kit promoter labels a fraction of the c-kit+ cells recognized by antibody labeling for c-kit protein. Expression of GFP by the c-kit promoter and accumulation of GFP-positive cells in the myocardium is relatively high at birth compared with adult and declines between postnatal weeks 1 and 2, which tracks in parallel with expression of c-kit protein and c-kit-positive cells. Acute cardiomyopathic injury by infarction prompts increased expression of both GFP protein and GFP-labeled cells in the region of infarction relative to remote myocardium. Similar increases were observed for c-kit protein and cells with a slightly earlier onset and decline relative to the GFP signal. Cells coexpressing GFP, c-kit, and cardiogenic markers were apparent at 1–2 weeks postinfarction. Cardiac-resident c-kit+ cell cultures derived from the transgenic line express GFP that is diminished in parallel with c-kit by induction of differentiation. The use of genetically engineered mice validates and extends the concept of c-kit+ cells participating in the response to myocardial injury.

Disclosure of potential conflicts of interest is found at the end of this article.

This article has been cited by other articles:

				J. A. Muraski, K. M. Fischer, W. Wu, C. T. Cottage, P. Quijada, M. Mason, S. Din, N. Gude, R. Alvarez Jr, M. Rota, et al. Pim-1 kinase antagonizes aspects of myocardial hypertrophy and compensation to pathological pressure overload PNAS, September 16, 2008; 105(37): 13889 - 13894. [Abstract] [Full Text] [PDF]

				S. Siddiqi, N. Gude, T. Hosoda, J. Muraski, M. Rubio, G. Emmanuel, J. Fransioli, S. Vitale, C. Parolin, D. D'Amario, et al. Myocardial Induction of Nucleostemin in Response to Postnatal Growth and Pathological Challenge Circ. Res., July 3, 2008; 103(1): 89 - 97. [Abstract] [Full Text] [PDF]